Abstract

A dramatic increase in the frequency of the H275Y mutation in the neuraminidase (NA), conferring resistance to oseltamivir, has been detected in human seasonal influenza A/H1N1 viruses since the influenza season of 2007–2008. The resistant viruses emerged in the ratio of 14.3% and quickly reached 100% in Taiwan from September to December 2008. To explore the mechanisms responsible for emergence and spread of the resistant viruses, we analyzed the complete genome sequences of 25 viruses collected during 2005–2009 in Taiwan, which were chosen from various clade viruses, 1, 2A, 2B-1, 2B-2, 2C-1 and 2C-2 by the classification of hemagglutinin (HA) sequences. Our data revealed that the dominant variant, clade 2B-1, in the 2007–2008 influenza emerged through an intra-subtype 4+4 reassortment between clade 1 and 2 viruses. The dominant variant acquired additional substitutions, including A206T in HA, H275Y and D354G in NA, L30R and H41P in PB1-F2, and V411I and P453S in basic polymerase 2 (PB2) proteins and subsequently caused the 2008–2009 influenza epidemic in Taiwan, accompanying the widespread oseltamivir-resistant viruses. We also characterized another 3+5 reassortant virus which became double resistant to oseltamivir and amantadine. Comparison of oseltamivir-resistant influenza A/H1N1 viruses belonging to various clades in our study highlighted that both reassortment and mutations were associated with emergence and spread of these viruses and the specific mutation, H275Y, conferring to antiviral resistance, was acquired in a hitch-hiking mechanism during the viral evolutionary processes.

Highlights

  • Influenza viruses cause annual epidemics in many countries and occasional worldwide pandemics

  • Increase of oseltamivir-resistant seasonal influenza A/H1N1 viruses in Taiwan from September 2008

  • From January 2005 to August 2008, a total of 47 seasonal influenza A/H1N1 viruses in Taiwan were tested for the presence of H275Y substitution in the NA and only two (4.2%) isolates, A/ Taiwan/0045/2006 and A/Taiwan/3293/2008, were shown to be positive for this substitution

Read more

Summary

Introduction

Influenza viruses cause annual epidemics in many countries and occasional worldwide pandemics. There have been two classes of antiviral drugs available for preventing and treating influenza illness: M2 ion channel blockers, adamantanes (amantadine and rimantadine), and neuraminidase inhibitors (oseltamivir, zanamivir and peramivir). Since the 2005–2006 influenza season, most human influenza A/H3N2 viruses circulating worldwide were found to carry S31N in the M2 protein, conferring to adamantane-resistance [1,2]. In the season of 2007–2008, oseltamivir-resistant seasonal influenza A/H1N1 viruses carrying H275Y (N1 numbering) in the NA protein were detected in Europe and spread globally in the absence of drug selective pressure [3,4,5]. Emergence and spread of antiviral-resistant viruses pose a challenge regarding the strategies for treating and preventing influenza

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call